arsenic trioxide has been researched along with glutamic acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Körper, S; Rojewski, MT; Schrezenmeier, H; Thiel, E | 1 |
| Baker, RT; Blackburn, AC; Board, PG; Brew, J; Cappello, J; Cavanaugh, JA; Coggan, M; Eyre, HJ; Schmuck, E; Sutherland, GR | 1 |
2 other study(ies) available for arsenic trioxide and glutamic acid
| Article | Year |
|---|---|
Arsenic trioxide-induced apoptosis is independent of CD95 in lymphatic cell lines.
Topics: Antibodies; Antigens, CD; Apoptosis; Arsenic Trioxide; Arsenicals; fas Receptor; Glutamic Acid; Growth Inhibitors; HL-60 Cells; Humans; Intracellular Membranes; Jurkat Cells; K562 Cells; Membrane Potentials; Mitochondria; Oxides | 2004 |
Deletion of Glu155 causes a deficiency of glutathione transferase Omega 1-1 but does not alter sensitivity to arsenic trioxide and other cytotoxic drugs.
Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cytotoxins; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Genotype; Glutamic Acid; Glutathione Transferase; Humans; Oxides; Polymorphism, Genetic | 2008 |